glp-1 efficacy Safety and of a and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial GLP-1 trends 2025: real-world data,
Description
therefore, while muscle mass goes down on scans, patients may be getting stronger, more mobile, and more physically capable
Supports metabolic health and curbs cravings
What to Expect with GLP-1 Treatment Patients may experience: Safe, steady weight loss Reduced body fat Improved blood sugar control Lower blood pressure and cholesterol Increased energy Better sleep and overall wellness Are There Side Effects
Patients should discuss currently approved, potentially covered weight loss options with their physician
Leptin decreases
